Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Development of an Accessible Cognitive Behavioral Therapy Digital Therapeutic for Individuals With Long COVID

NCT: NCT07714889 · WITHDRAWN

NCT IDNCT07714889
StatusWITHDRAWN
Start Date2026-07
Completion2026-09
SponsorToivoa Inc (INDUSTRY)
First posted
Last updated

Brief Summary

This study will evaluate Toivoa-004 as an experimental digital therapeutic for persons with Long COVID suffering from anxiety or depression. This study will evaluate the completion rates of the Toivoa-004 program and survey the user's experience upon completion. Changes in anxiety and depression scores will be monitored during the study.

Frequently Asked Questions

What is Development of an Accessible Cognitive Behavioral Therapy Digital Therapeutic for Individuals With Long COVID?

Development of an Accessible Cognitive Behavioral Therapy Digital Therapeutic for Individuals With Long COVID is a clinical trial registered under NCT07714889. Current status: WITHDRAWN.

What is the status of NCT07714889?

The current status of NCT07714889 (Development of an Accessible Cognitive Behavioral Therapy Digital Therapeutic for Individuals With Long COVID) is: WITHDRAWN.

When did Development of an Accessible Cognitive Behavioral Therapy Digital Therapeutic for Individuals With Long COVID start?

Development of an Accessible Cognitive Behavioral Therapy Digital Therapeutic for Individuals With Long COVID started on 2026-07.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑